Cargando…
(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment
BACKGROUND: The aim of this study was to evaluate (18)F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography ((18)F-RGD PET/CT) and serum inflammation biomarkers for predicting outcomes of patients receiving combined antiangiogenic treatment for advanced non-small cell lung cancer (NSCLC)...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212050/ https://www.ncbi.nlm.nih.gov/pubmed/34150635 http://dx.doi.org/10.3389/fonc.2021.671912 |